doi: 10.1007/BF00254544.
Epipodophyllotoxin (VP16-213) in small cell carcinoma of the Bronchus resistant to initial combination chemotherapy
- PMID: 6282480
- DOI: 10.1007/BF00254544
Item in Clipboard
Epipodophyllotoxin (VP16-213) in small cell carcinoma of the Bronchus resistant to initial combination chemotherapy
Cancer Chemother Pharmacol.
1982.
Abstract
Thirty-eight patients with small cell carcinoma of the bronchus resistant to initial chemotherapy with cyclophosphamide methotrexate and CCNU, were treated with VP16-213 alone in a dose of 120 mg/m2 i.v. on days 1, 3, and 5 every 3 weeks. Twelve patients died before three courses of treatment. In 26 patients who received three or more courses only one, transient partial response occurred. One or more components of the initial chemotherapy seems to confer resistance to the action of VP16-213 in this disease.
Similar articles
-
Doxorubicin, Cyclophosphamide and VP16-213 (ACE) in the treatment of small cell lung cancer.Cancer Chemother Pharmacol. 1982;7(2-3):187-93. doi: 10.1007/BF00254546. Cancer Chemother Pharmacol. 1982. PMID: 6282482 Clinical Trial.
-
VP16-213 in combined modality treatment of small cell carcinoma of the lung.Eur J Cancer Clin Oncol. 1982 Apr;18(4):343-6. doi: 10.1016/0277-5379(82)90004-9. Eur J Cancer Clin Oncol. 1982. PMID: 6288390
-
Treatment of small cell lung cancer with a combination of VP16-213 and cyclophosphamide with cisplatin or radiotherapy.Cancer Chemother Pharmacol. 1982;7(2-3):181-6. doi: 10.1007/BF00254545. Cancer Chemother Pharmacol. 1982. PMID: 6282481
-
[Etoposide. A new highly effective cytostatic agent in anaplastic small-cell bronchial carcinoma, other solid tumors and hemoblastoses].Dtsch Med Wochenschr. 1981 Aug 28;106(35):1105-9. doi: 10.1055/s-2008-1070465. Dtsch Med Wochenschr. 1981. PMID: 6266800 Review. German. No abstract available.
-
Podophyllotoxin derivative VP 16-213.Cancer Chemother Pharmacol. 1979;3(2):71-80. doi: 10.1007/BF00254976. Cancer Chemother Pharmacol. 1979. PMID: 389478 Review.
Cited by
-
An etoposide-resistant lung cancer subline overexpresses the multidrug resistance-associated protein.Br J Cancer. 1995 Sep;72(3):535-42. doi: 10.1038/bjc.1995.370. Br J Cancer. 1995. PMID: 7669558 Free PMC article.
-
Chemotherapy in non-small cell bronchial carcinoma.Thorax. 1985 Sep;40(9):641-5. doi: 10.1136/thx.40.9.641. Thorax. 1985. PMID: 4060103 Free PMC article. No abstract available.
-
Etoposide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in combination chemotherapy of cancer.Drugs. 1990 Mar;39(3):438-90. doi: 10.2165/00003495-199039030-00008. Drugs. 1990. PMID: 2184009 Review. No abstract available.
-
VP16-213 (etoposide). A critical review of its activity.Cancer Chemother Pharmacol. 1982;7(2-3):81-5. doi: 10.1007/BF00254526. Cancer Chemother Pharmacol. 1982. PMID: 7044594 Review. No abstract available.